Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus
Clinical trial NCT02529449 · COMPLETED
Trial details
- NCT number
- NCT02529449
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-03-19
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.